AI & Enterprise
Google DeepMind unveils Alphagenome 2 AI to pinpoint causes of disease
Google DeepMind has unveiled Alphagenome 2, a genome AI model designed to predict how DNA variants affect cells depending on their type and biological state. The company says the model, trained on more than 100 million single-cell profiles from 68 tissues, can identify nearly twice as many variants that may alter gene expression as the previous best model. DeepMind said the tool can make predictions for new cell types without retraining and will be available via an API for non-commercial research.
